Sedana Medical AB fourth quarter and year-end report 2021
Sales at an all-time-high provide a strong platform for launchFourth quarter 2021 · Net sales totalled MSEK 46 (46), equivalent to an increase of 1% compared to the fourth quarter of 2020. At constant exchange rates, sales increased by 2%. · Gross profit was MSEK 33 (30), equivalent to a margin of 71% (64%). The improved margin is primarily an effect of lower transportation costs, a favourable country mix and timing effects. · Earnings before interest, taxes, depreciation and amortisation (EBITDA) totalled MSEK -13 (-6), equivalent to an EBITDA margin of -29% (-13%). ·